Clinical Trials

Showing trials with last updates posted in 2025.

NCT03638167 | COMPLETED | PHASE1
11 participants

EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-17
Start Date:
2019-03-19
Completion:
2023-12-22
Conditions
  • Central Nervous System Tumor, Pediatric
  • Glioma
  • Ependymoma
  • Medulloblastoma
  • Germ Cell Tumor
  • Atypical Teratoid/Rhabdoid Tumor
  • Primitive Neuroectodermal Tumor
  • Choroid Plexus Carcinoma
  • Pineoblastoma
Interventions
  • BIOLOGICAL
No Results Yet
NCT03623464 | ACTIVE_NOT_RECRUITING | NA
107 participants

RCT of Mobile Apps & FitBit v. Usual Care

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-17
Start Date:
2017-05-31
Completion:
2026-06-30
Conditions
  • Pancreatic Cancer
  • Gastric Cancer
  • Hepatic Cancer
  • Colon Cancer
  • Rectal Cancer
  • Small Bowel Cancer
Interventions
  • OTHER
No Results Yet
NCT03500991 | ACTIVE_NOT_RECRUITING | PHASE1
10 participants

HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-17
Start Date:
2018-07-26
Completion:
2024-01-17
Conditions
  • Central Nervous System Tumor, Pediatric
  • Glioma
  • Ependymoma
  • Medulloblastoma
  • Germ Cell Tumor
  • Atypical Teratoid/Rhabdoid Tumor
  • Primitive Neuroectodermal Tumor
  • Choroid Plexus Carcinoma
  • Pineoblastoma
Interventions
  • BIOLOGICAL
No Results Yet
NCT03471130 | COMPLETED | PHASE1
48 participants

Definitive QT Study With MT-8554

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-17
Start Date:
2018-04-23
Completion:
2018-10-19
Conditions
  • Healthy Volunteer
Interventions
  • DRUG
No Results Yet
NCT03381404 | COMPLETED | PHASE1
6 participants

Mass Balance Study With MT-8554

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-17
Start Date:
2017-12-19
Completion:
2018-01-29
Conditions
  • Healthy Volunteer
Interventions
  • DRUG
No Results Yet
NCT03065881 | COMPLETED | NA
664 participants

RETeval All Comers Trial (REACT)

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-17
Start Date:
2017-02-13
Completion:
2021-12-21
Conditions
  • Retinal Disease, Electroretinogram
Interventions
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page